4//SEC Filing
Chee Conley 4
Accession 0000950170-24-120866
CIK 0001556263other
Filed
Nov 3, 7:00 PM ET
Accepted
Nov 4, 5:01 PM ET
Size
8.7 KB
Accession
0000950170-24-120866
Insider Transaction Report
Form 4
Chee Conley
Chief Commercial Officer
Transactions
- Tax Payment
Common Stock
2024-10-31$2.09/sh−8,707$18,198→ 130,797 total - Exercise/Conversion
Common Stock
2024-10-31+17,000→ 139,504 total - Exercise/Conversion
Restricted Stock Units
2024-10-31−17,000→ 0 total→ Common Stock (17,000 underlying)
Footnotes (4)
- [F1]Represents shares of common stock received upon vesting of a restricted stock unit award.
- [F2]Represents shares used to cover tax withholding on a restricted stock unit release.
- [F3]Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.
- [F4]Represents a restricted stock unit award granted on October 6, 2022. These restricted stock units vested as to one half (50%) of the shares on October 31, 2023, and as to one half (50%) of the shares on October 31, 2024.
Documents
Issuer
Syros Pharmaceuticals, Inc.
CIK 0001556263
Entity typeother
Related Parties
1- filerCIK 0001883804
Filing Metadata
- Form type
- 4
- Filed
- Nov 3, 7:00 PM ET
- Accepted
- Nov 4, 5:01 PM ET
- Size
- 8.7 KB